NCT04526886 · OUTCOME

Unplanned Chemotherapy Treatment Delay

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy · Source last updated 2025-10-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: Through day 1 of cycle 6 of FOLFOX chemotherapy (cycle length is 14 days)

What was measured

Number of patients with any interruption of chemotherapy leading to a cycle length of \>18 days that is not anticipated as of day 3 of the preceding treatment cycle.

Groups in this outcome

Evaluable Participants

All study participants evaluable for the primary outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Evaluable Participants	48

Reported measurements

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Evaluable Participants	16	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
16

denoms

counts
group Id
OG000
value
48
units
Participants

description

Number of patients with any interruption of chemotherapy leading to a cycle length of \>18 days that is not anticipated as of day 3 of the preceding treatment cycle.

groups

description
All study participants evaluable for the primary outcome
id
OG000
title
Evaluable Participants

param Type

COUNT_OF_PARTICIPANTS

reporting Status

POSTED

time Frame

Through day 1 of cycle 6 of FOLFOX chemotherapy (cycle length is 14 days)

title

Unplanned Chemotherapy Treatment Delay

type

PRIMARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice